POET Technologies Inc. surged as investors cheered its latest optical chip partnership, with stocks have been trading up by 12.8 percent.
Key Takeaways For POET Traders
- POET Technologies signed a strategic Lumilens partnership for wafer-level photonic integration in frontier AI, backed by a $50M initial order that may scale above $500M over five years.
- Following the Lumilens announcement, POET’s shares ripped 33–39% on heavy volume, a classic momentum reset tied directly to the AI-focused supply agreement.
- POET closed a US$400M non-brokered registered direct deal at a small premium, issuing 19,047,620 shares plus three-year warrants struck 25% higher at $26.15.
- The $400M cash haul targets a roughly 10x manufacturing capacity build-out, faster hiring, R&D scale-up, light-source acceleration, potential M&A, and general working capital.
- Q1 2026 results still showed minimal revenue and a sizable loss, but POET highlighted the Lumilens $50M order, fresh LITEON and Lessengers collaborations, and a planned U.S. redomiciling.
Live Update At 11:32:14 EDT: On Friday, June 12, 2026 POET Technologies Inc. stock [NASDAQ: POET] is trending up by 12.8%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
POET Technologies is trading like a high-beta AI hardware story, not a mature cash cow. The daily chart from 2026/05/18 through 2026/06/12 shows big swings, with POET spiking to the mid‑$15s before sliding into the low‑$11s and then rebounding to close near $12.69 on 2026/06/12. That’s a volatile ride, but the uptrend off the recent lows is clear.
Intraday on 2026/06/12, POET opened around $11.15, flushed briefly near $11.02, then trended higher through the morning, grinding into the high‑$12s by late session. The tape shows steady higher lows and controlled pullbacks, which short-term traders look for when momentum is rebuilding.
More Breaking News
- ELVN Stock Draws Bullish Targets As Trial Data Builds Momentum
- Entegris (ENTG) Stock Firms As EUV, WFE Tailwinds Build
- LASE Stock Surges As Defense And Industrial Demand Heat Up
- CoreWeave Stock Rallies As AI Data Center And Nasdaq-100 Catalysts Build
Fundamentally, POET is still early. Q1 2026 revenue was only about $1.1M, with gross margin at 100% but operating expenses near $18.4M and a net loss of roughly $12.3M. Key ratios scream “growth stage”: price‑to‑sales above 700, deeply negative returns on equity and assets, but almost no leverage and a huge current ratio above 35. For traders, that combination — tiny revenue, big loss, strong balance sheet — says story stock tied to execution on its new AI deals, not balance-sheet distress.
Why Traders Are Watching POET’s AI Pivot
POET Technologies has finally put real numbers behind its AI narrative. The headline driver is the Lumilens supply and technology partnership. POET locked in a $50M initial purchase order for its Electrical‑Optical Interposer (EOI)‑based engines, targeting frontier AI infrastructure. The kicker is the scale: management framed the deal as potentially exceeding $500M over five years. For a company with barely $0.5M in quarterly revenue, that’s a step‑change.
Traders saw it right away. When POET announced the Lumilens agreement on 2026/05/14, the stock exploded 33–39% on heavy volume. That’s not slow money repositioning — that’s momentum trading chasing a perceived inflection point. POET went from a speculative photonics name to a real AI supply‑chain player with line of sight to multi‑year orders.
At the same time, the Q1 2026 report reminded everyone this is still pre‑scale. Revenue remains immaterial, and POET booked a sizable net loss. But management stacked several strategic updates: Lumilens, collaborations with LITEON and Lessengers, a planned U.S. redomiciling, and a routine Form 6‑K filing to keep U.S. disclosure tight. The message to the market is simple: POET wants to sit closer to the AI and data center capital flows — and is repositioning its corporate structure and partnerships to get there.
For short-term traders, this mix of huge contract headlines, thin current revenue, and aggressive positioning is the classic recipe for sharp trend moves and violent pullbacks.
Conclusion
The second big chapter in POET Technologies’ story is the US$400M registered direct offering. POET sold 19,047,620 common shares plus three‑year warrants for the same number of shares at a combined $21.00, a slight premium to the prior close. Those warrants sit at $26.15 — roughly a 25% premium — creating a clear potential ceiling where warrant holders may look to lock in gains.
The market’s reaction was textbook. After the financing announcement around 2026/05/18, POET dropped about 10% as traders priced in dilution and future warrant overhang. But structurally, this is a war chest raise. Management plans to use the $400M for roughly 10x capacity expansion, heavier hiring and facilities build‑out, R&D scale‑up, a faster light‑source push, and potential acquisitions or partnerships to scale its photonic interconnects for AI and data centers.
So where does that leave POET traders now? The stock has a massive AI contract pipeline narrative, high volatility on the chart, and fresh capital to try to deliver. But the financials still show tiny revenue and heavy losses, which means execution risk is front and center.
This is exactly the kind of setup Tim Sykes talks about when he says, “Volatile story stocks are the best teachers — respect the hype, but trade the price action, cut losses fast, and never fall in love with a ticker.” As millionaire penny stock trader and teacher Tim Sykes, says, “It’s better to go home at zero than to go home in the red.”. For POET Technologies, that means treating the Lumilens deal and $400M raise as catalysts to trade around, not guarantees — using the chart, liquidity, and key levels to guide every decision. This article is for educational and research purposes only and is not investment advice.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



Leave a reply